AI English summary of an SEC filing — figures as filed
Honeywell HONThe company said its Q3 sales were $9,728 million, up 6% from $9,212 million a year earlier, and that organic sales rose 3%. Operating margin was 19.1%, down 180 basis points, which the company cited as mainly due to an impairment related to classifying the personal protective equipment (PPE) business as assets held for sale.
Key points
AI summaryThe company said its Q3 sales were $9,728 million, up 6% from $9,212 million a year earlier, and that organic sales rose 3%. Operating margin was 19.1%, down 180 basis points, which the company cited as mainly due to an impairment related to classifying the personal protective equipment (PPE) business as assets held for sale.
The company concluded that the assets and liabilities of the PPE business met the held-for-sale criteria as of September 30, 2024. In Q3, it recognized a valuation allowance of $125 million to write down the disposal group to fair value less costs to sell, and an impairment charge of $37 million (after tax) on indefinite-lived intangible assets.
The company said operating cash flow for Q3 was $1,997 million, up 10% from $1,809 million a year earlier. Free cash flow, defined as operating cash flow less capital expenditures of $279 million, was $1,718 million, up 10% from $1,560 million a year earlier.
The company said it updated its full-year sales guidance to $38.6B to $38.8B from the prior $39.1B to $39.7B, and its operating cash flow guidance to $6.2B to $6.5B from $6.6B to $7.0B. It presented adjusted EPS guidance of $10.15 to $10.25, compared with the prior $10.05 to $10.25.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the opening part of the filing body and confirmed exhibits, within a length limit. This is not a review of other exhibits, investor presentations or the full earnings call.
Q3 Sales and Operating Margin
The company said its Q3 sales were $9,728 million, up 6% from $9,212 million a year earlier, and that organic sales rose 3%. Operating margin was 19.1%, down 180 basis points, which the company cited as mainly due to an impairment related to classifying the personal protective equipment (PPE) business as assets held for sale.
Source · Based on the filing body and exhibits
Valuation Allowance and Impairment Related to PPE Business Sale
The company concluded that the assets and liabilities of the PPE business met the held-for-sale criteria as of September 30, 2024. In Q3, it recognized a valuation allowance of $125 million to write down the disposal group to fair value less costs to sell, and an impairment charge of $37 million (after tax) on indefinite-lived intangible assets.
Source · Based on the filing body and exhibits
Q3 Operating Cash Flow and Free Cash Flow
The company said operating cash flow for Q3 was $1,997 million, up 10% from $1,809 million a year earlier. Free cash flow, defined as operating cash flow less capital expenditures of $279 million, was $1,718 million, up 10% from $1,560 million a year earlier.
Source · Based on the filing body and exhibits
Full-Year Outlook Update
The company said it updated its full-year sales guidance to $38.6B to $38.8B from the prior $39.1B to $39.7B, and its operating cash flow guidance to $6.2B to $6.5B from $6.6B to $7.0B. It presented adjusted EPS guidance of $10.15 to $10.25, compared with the prior $10.05 to $10.25.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…